Drug
Methotrexate
Methotrexate: highest development phase Phase 3, developed by Grifols, Incyte, Roche. 3 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Grifols, Incyte, Roche
Trials
| Drug | Phase | Indication |
|---|---|---|
| Methotrexate (MTX) NCT06615050 | Phase 3 | Graft-versus-host Disease (GVHD) |
| methotrexate NCT01235507 | Phase 3 | Rheumatoid Arthritis |
| Methotrexate NCT02772965 | Phase 3 | Pediatric Crohn's Disease |
Latest
No recent events.
Follow Methotrexate on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.